- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statement Nos. 333-38094, 333-83089, 333-84183, 333-108716, 333-125743, 333-144221, 333-150253, 333-158595, 333-166067, 333-173206, 333-181564, 333-188860 and 333-197557 on Form S-8 and Registration Statement Nos. 333-183153, 333-189831 and 333-198878 on Form S-3 of our reports dated December 10, 2014, relating to the consolidated financial statements and internal control over financial reporting of AVANIR Pharmaceuticals, Inc. and subsidiaries appearing in this Annual Report on Form 10-K of AVANIR Pharmaceuticals, Inc. for the year ended September 30, 2014.
/s/ KMJ Corbin & Company LLP
Costa Mesa, California
December 10, 2014